Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Planet Labs PBC (PL-WT) Cash & Equivalents (2020 - 2026)

Planet Labs PBC's Cash & Equivalents history spans 5 years, with the latest figure at $133.5 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents rose 24.31% year-over-year to $133.5 million; the TTM value through Apr 2025 reached $133.5 million, up 24.31%, while the annual FY2025 figure was $6.6 million, 92.14% down from the prior year.
  • Cash & Equivalents for Q2 2025 was $133.5 million at Planet Labs PBC, up from $6.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $496.8 million in Q1 2022 and bottomed at $6.5 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $101.5 million (2023), against an average of $157.7 million.
  • The largest annual shift saw Cash & Equivalents surged 549.09% in 2022 before it crashed 93.57% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $81.2 million in 2021, then skyrocketed by 229.91% to $267.8 million in 2022, then tumbled by 62.09% to $101.5 million in 2023, then plummeted by 93.57% to $6.5 million in 2024, then skyrocketed by 1945.53% to $133.5 million in 2025.
  • Per Business Quant, the three most recent readings for PL-WT's Cash & Equivalents are $133.5 million (Q2 2025), $6.6 million (Q1 2025), and $6.5 million (Q4 2024).